N-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclohexanamine, 97%, 1g

2-Bromo-6-fluoro-3-hydroxybenzoic acid, 97%, 500mg

Methyl 2-acetamidoacrylate, 95.0%, 10g

(6-((Tert-butoxycarbonyl)(methyl)amino)pyridin-3-yl)boronic acid, 98%, 250mg

4-(2-Carboxyethyl)benzoic acid methyl ester, 95.0%, 25g

3-(4-Bromobenzyl)-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid, 98%, 1g

2-(METHYLAMINO)PHENOL, 95.0%, 10g

NHS C3 azides, ≥95%, 10 mg, plastic packaging.

4-Cyclopropoxybenzoic acid, 98%, 250mg

2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione, 95.0%, 25mg

1-Acetyl-3-methylpiperidine, 1g

N6-Methylquinoline-5,6-diamine, 95%, 250mg

11-(Bromomethyl)tricosane>95.0%(GC)5mL